# Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2

> **NCT00383604** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 30 (actual)

## Conditions studied

- Lymphedema
- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00383604
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2012-03
- **Final completion:** 2012-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383604, "Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00383604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*